Table I.
Total white blood cells and cellular composition in the BALF.
| Group | Total cells (×106) | Cellular Composition (%)
|
|||
|---|---|---|---|---|---|
| Macrophages | Eosinophils | Neutrophils | Lymphocytes | ||
| Control | 3.64±0.20 | 94.06±0.45 | 1.45±0.09 | 1.33±0.48 | 3.52±1.31 |
| OVA | 12.23±0.43a | 57.75±0.63a | 4.58±0.19a | 32.05±0.79a | 5.61±0.85 |
| NGF | 17.18±0.44b | 50.13±0.69b | 5.42±0.15c | 37.75±0.37b | 6.68±0.58a |
| Anti-NGF | 5.43±0.36b | 81.25±0.62b | 2.96±0.23b | 11.37±0.56b | 4.41±0.63 |
Values are expressed as the mean ± standard error of the mean of 8 rats in each treatment group.
a
P<0.01 compared with the control group,
b
P<0.01 and
c
P<0.05 compared with the OVA group. BALF, bronchoalveolar lavage fluid; OVA, ovalbumin; NGF, nerve growth factor.